Literature DB >> 10723109

Linkage analysis of 150 high-risk prostate cancer families at 1q24-25.

E L Goode1, J L Stanford, L Chakrabarti, M Gibbs, S Kolb, R A McIndoe, V A Buckley, E F Schuster, C L Neal, E L Miller, S Brandzel, L Hood, E A Ostrander, G P Jarvik.   

Abstract

Confirmation of linkage and estimation of the proportion of families who are linked in large independent datasets is essential to understanding the significance of cancer susceptibility genes. We report here on an analysis of 150 high-risk prostate cancer families (2,176 individuals) for potential linkage to the HPC1 prostate cancer susceptibility locus at 1q24-25. This dataset includes 640 affected men with an average age at prostate cancer diagnosis of 66. 8 years (range, 39-94), representing the largest collection of high-risk families analyzed for linkage in this region to date. Linkage to multiple 1q24-25 markers was strongly rejected for the sample as a whole (lod scores at theta = 0 ranged from -30.83 to -18. 42). Assuming heterogeneity, the estimated proportion of families linked (alpha) at HPC1 in the entire dataset was 2.6%, using multipoint analysis. Because locus heterogeneity may lead to false rejection of linkage, data were stratified based on homogeneous subsets. When restricted to 21 Caucasian families with five or more affected family members and mean age at diagnosis < = 65 years, the lod scores at theta = 0 remained less than -4.0. These results indicate that the overall portion of hereditary prostate cancer families whose disease is due to inherited variation in HPC1 may be less than originally estimated. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10723109     DOI: 10.1002/(SICI)1098-2272(200003)18:3<251::AID-GEPI5>3.0.CO;2-X

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  7 in total

1.  Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.

Authors:  K A Goddard; J S Witte; B K Suarez; W J Catalona; J M Olson
Journal:  Am J Hum Genet       Date:  2001-04-13       Impact factor: 11.025

2.  A genomic scan of families with prostate cancer identifies multiple regions of interest.

Authors:  M Gibbs; J L Stanford; G P Jarvik; M Janer; M Badzioch; M A Peters; E L Goode; S Kolb; L Chakrabarti; M Shook; R Basom; E A Ostrander; L Hood
Journal:  Am J Hum Genet       Date:  2000-05-19       Impact factor: 11.025

3.  Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Authors:  Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth Gillanders; Suzanne Kolb; Katherine E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

4.  Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Authors:  Phillippa J Neville; David V Conti; Pamela L Paris; Howard Levin; William J Catalona; Brian K Suarez; John S Witte; Graham Casey
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

Review 5.  Genetics of prostate cancer: too many loci, too few genes.

Authors:  E A Ostrander; J L Stanford
Journal:  Am J Hum Genet       Date:  2000-11-07       Impact factor: 11.043

6.  The clinical genetics of prostate cancer.

Authors:  Sashi Kommu; Stephen Edwards; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

Review 7.  Prostate cancer genomics.

Authors:  P E Li; P S Nelson
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.